2013
The cost implications of prostate cancer screening in the Medicare population
Ma X, Wang R, Long JB, Ross JS, Soulos PR, Yu JB, Makarov DV, Gold HT, Gross CP. The cost implications of prostate cancer screening in the Medicare population. Cancer 2013, 120: 96-102. PMID: 24122801, PMCID: PMC3867600, DOI: 10.1002/cncr.28373.Peer-Reviewed Original ResearchConceptsProstate cancerScreening costsAnnual screening costsPopulation-based cohortProstate cancer screeningHospital referral region levelMale Medicare beneficiariesProstate-specific antigenCancer screeningLowest quartileHRR levelMedicare populationMedicare beneficiariesOlder menNational feeCancerService Medicare programCancer diagnosisMenQuartilePSACost implicationsAnnual expenditureMedicare programBiopsy
2010
Laboratory Test Ordering at Physician Offices with and without On-Site Laboratories
Bishop TF, Federman AD, Ross JS. Laboratory Test Ordering at Physician Offices with and without On-Site Laboratories. Journal Of General Internal Medicine 2010, 25: 1057-1063. PMID: 20532656, PMCID: PMC2955467, DOI: 10.1007/s11606-010-1409-7.Peer-Reviewed Original ResearchConceptsProstate-specific antigenConfidence intervalsNational Ambulatory Medical Care SurveyAmbulatory Medical Care SurveyPrimary care physiciansDesignCross-sectional studyPhysician ownersGroup practiceHealth care servicesLaboratory testsCommon laboratory testsExcess healthcare spendingGroup practice physiciansCare physiciansBlood countCare SurveyPhysician's officePrimary analysisPractice characteristicsCare servicesSecondary analysisKey ResultsThereSite laboratoryVisitsAOR